As of 2024-12-15, the Intrinsic Value of Maravai LifeSciences Holdings Inc (MRVI) is
29.55 USD. This MRVI valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 5.67 USD, the upside of Maravai LifeSciences Holdings Inc is
421.10%.
The range of the Intrinsic Value is 24.53 - 37.46 USD
29.55 USD
Intrinsic Value
MRVI Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
24.53 - 37.46 |
29.55 |
421.1% |
| DCF (Growth 10y) |
28.17 - 42.27 |
33.66 |
493.7% |
| DCF (EBITDA 5y) |
47.69 - 53.66 |
50.53 |
791.1% |
| DCF (EBITDA 10y) |
45.56 - 56.04 |
50.42 |
789.3% |
| Fair Value |
-22.24 - -22.24 |
-22.24 |
-492.26% |
| P/E |
(26.28) - 67.32 |
18.20 |
221.0% |
| EV/EBITDA |
56.03 - 60.15 |
57.87 |
920.7% |
| EPV |
11.31 - 15.42 |
13.36 |
135.7% |
| DDM - Stable |
(5.18) - (10.28) |
(7.73) |
-236.3% |
| DDM - Multi |
14.25 - 22.83 |
17.61 |
210.5% |
MRVI Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,431.85 |
| Beta |
1.19 |
| Outstanding shares (mil) |
252.53 |
| Enterprise Value (mil) |
1,407.49 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.41% |
| Cost of Debt |
5.25% |
| WACC |
8.80% |